Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis

Am J Otolaryngol. 2020 May-Jun;41(3):102434. doi: 10.1016/j.amjoto.2020.102434. Epub 2020 Feb 17.

Abstract

Background: Anaplastic thyroid carcinoma (ATC) is a refractory and poor prognosis tumor Present study aimed to investigate the underlying biological functions and pathways involved in the development of ATC and to identify potential hub genes and candidate biomarkers of ATC.

Materials and methods: Bioinformatics analyses were performed to identify the differentially expressed genes (DEGs) between ATC tissue samples and adjacent normal tissue samples. Protein-protein interaction (PPI) networks of the DEGs were constructed using Search Tool for the Retrieval of Interacting Genes online tool and Cytoscape software and divided into sub-networks using the Molecular Complex Detection (MCODE) plug-in. DEGs in each module was analyzed by enrichment analysis of the KEGG Orthology Based Annotation System (KOBAS) web software version 3.0. Eventually, the hub genes from bioinformatics analysis were verified by qRT-PCR assay in different ATC cell lines.

Results: Thirty hub genes were selected and three modules were built by the Cytoscape software from the PPI network. Seven genes (CDK1, CCNB2, BUB1B, CDC20, RRM2, CHEK1 and CDC45) were screened from thirty hub genes. Enrichment analysis showed that these hub genes were primarily accumulated in 'cell cycle', 'p53 signaling pathway', 'viral carcinogenesis', 'pyrimidine metabolism' and 'ubiquitin mediated proteolysis'. The results of qRT-PCR indicated that seven hub genes were unregulated in three ATC cell lines compared with normal thyroid gland cell.

Conclusions: These findings suggest that CDK1, CCNB2, BUB1B, CDC20, RRM2, CHEK1 and CDC45 may serve as novel diagnosis biomarkers and potential therapeutic target for ATC.

Keywords: Anaplastic thyroid cancer; Bioinformatics analysis; Differentially expressed genes; Quantitative real-time PCR.

MeSH terms

  • CDC2 Protein Kinase / genetics*
  • Cdc20 Proteins
  • Cell Cycle / genetics
  • Cell Cycle Proteins / genetics*
  • Cell Line, Tumor
  • Checkpoint Kinase 1 / genetics
  • Computational Biology / methods*
  • Cyclin B2 / genetics*
  • Genetic Association Studies / methods*
  • Genetic Markers
  • Humans
  • Molecular Targeted Therapy
  • Protein Serine-Threonine Kinases / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Ribonucleoside Diphosphate Reductase / genetics
  • Signal Transduction / genetics*
  • Thyroid Neoplasms / diagnosis
  • Thyroid Neoplasms / genetics*
  • Thyroid Neoplasms / metabolism*
  • Thyroid Neoplasms / pathology

Substances

  • BUB1B protein, human
  • CCNB2 protein, human
  • CDC45 protein, human
  • Cdc20 Proteins
  • Cell Cycle Proteins
  • Cyclin B2
  • Genetic Markers
  • CDC20 protein, human
  • ribonucleotide reductase M2
  • Ribonucleoside Diphosphate Reductase
  • CHEK1 protein, human
  • Checkpoint Kinase 1
  • Protein Serine-Threonine Kinases
  • CDC2 Protein Kinase
  • CDK1 protein, human